In neurodegenerative diseases, such as AD and AD-related tauopathies (foldopathies) [207], tau is highly phosphorylated and has a tighter more folded conformation and is remarkably more susceptible to aggregate than non-phosphorylated tau [208,209]. This evidence concerns the gene MAPT and Alzheimer disease.